Is Biomea Fusion, Inc. (BMEA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 8.9% / 30% | 59.3% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 8.9% / 33% | 59.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 11.0% / 33% | 72.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 8.9% / 33% | 59.3% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 11.0% / 33% | 72.9% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -152.4% | |
| Return on Assets (ROA) | -73.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$120M |
| Free Cash Flow | -$120M |
| Total Debt | $9M |
| Debt-to-Equity | 5.4 |
| Current Ratio | 5.2 |
| Total Assets | $80M |
Price & Trading
| Last Close | $1.37 |
| 50-Day MA | $1.29 |
| 200-Day MA | $1.56 |
| Avg Volume | 1.1M |
| Beta | -0.2 |
|
52-Week Range
$0.87
| |
About Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Biomea Fusion, Inc. (BMEA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Biomea Fusion, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Biomea Fusion, Inc.'s debt ratio?
Biomea Fusion, Inc.'s debt ratio is 8.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 11.0%.
What are Biomea Fusion, Inc.'s key financial metrics?
Biomea Fusion, Inc. has a market capitalization of $95M. Return on equity stands at -152.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.